|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on May 6, 2021. The analyst firm set a price target for 21.00 expecting AUTL to rise to within 12 months (a possible 207.47% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $6.83 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Autolus Therapeutics.
There is no upcoming split for Autolus Therapeutics.
Autolus Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.